← Back to Search

Mechanical Stimulation

Real AMPS for Cerebral Palsy

N/A

Waitlist Available

Led By David Putrino, PT, PhD

Research Sponsored by Icahn School of Medicine at Mount Sinai

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre and post-amps (baseline and 2 minutes)

Awards & highlights

Study Summary

This trial will study the effects of a Gondola device on patients with chronic stroke, cerebral palsy, and Parkinson's Disease. Data will be collected using standardized outcome measures and transcranial magnetic stimulation assessment protocol including electrical stimulation and electromyographic recording.

Eligible Conditions

Cerebral Palsy
Stroke
Parkinson's Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre and post-amps (baseline and 2 minutes)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre and post-amps (baseline and 2 minutes)

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre and post-amps (baseline and 2 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Soleus MVC

Secondary outcome measures

Change in 10 meter walk test

Change in Tibialis anterior MVC

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Real AMPSActive Control1 Intervention

AMPS therapy consists of mechanical stimulations applied to two specific points on both feet: the tip of the big toe (hallux) and the first metatarsal joint.

Group II: Sham AMPSPlacebo Group1 Intervention

AMPS therapy applied to two non-specific points on both feet.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor

860 Previous Clinical Trials

524,476 Total Patients Enrolled

David Putrino, PT, PhDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai

5 Previous Clinical Trials

465 Total Patients Enrolled

Gabriela RozanskiStudy DirectorMOUNT SINAI HOSPITAL

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the research team accept applicants below fifty years of age?

"This clinical trial is recruiting participants aged between 18 and 80. Meanwhile, there are 167 trials available for minors under the age of 18 and 534 studies enrolling seniors above 65 years old."

Answered by AI

What are the eligibility requirements for participation in this experiment?

"This clinical trial seeks 80 individuals, aged 18 to 80, diagnosed with cerebral palsy. Other eligible candidates must have experienced a chronic stroke lesion >6 months after an ischemic event or Parkinson's disease and possess some degree of motor function in the ankle flexor (soleus motor power greater than 1). Additionally, they need to be able walk 10 meters without assistance."

Answered by AI

Are there any openings left to enroll in this research experiment?

"Sadly, clinicaltrials.gov does not show any active recruitment for this trial which went live on December 1st of 2022 and was last updated in mid-June. Nonetheless, 665 other trials are currently recruiting participants at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Gondola Mechanism of Action

David Putrino 2023. "Gondola Mechanism of Action". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05146648.